Publicidad

Localización gamagráfica preoperatoria de adenomas en el hiperparatiroidismo primario; comparación con la ecografía

Referencias

  1. Prats E, Razola P, Tardín L, Andrés A, García López F, Abós MD et al. Gammagrafía de paratiroides y cirugía radiodirigida en el hiperparatiroidismo primario. Rev Esp Med Nucl 2007;26:310-28.
  2. Eslamy HK, Ziessman HA. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Radiographics 2008; 28:1461-76.
  3. Del Rio P, Cataldo S, Sommaruga L, Arcuri MF, Massa M, Sianesi M. Localization of pathological gland's site in primary hyperparathyroidism: ten years experience with MIBI scintigraphy. G Chir 2008;29:186-9.
  4. Fakhran S, Branstetter BF 4th, Pryma DA. Parathyroid imaging. Neuroimag Clin N Am 2008;18:537-49.
  5. Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med 2001;28:1409-20.
  6. Hindié E, Ugur O, Fuster D, O'Doherty M, Grassetto G, Ureña P et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 2009;36:1201-16.
  7. Harrell RM, Bimston DN. Optimization of minimally invasive radio-guided parathyroidectomy: the importance of neck ultrasonography and intraoperative parathyroid hormone assay. Endocr Pract 2008;14:856-62.
  8. Tublin ME, Pryma DA, Yim JH, Ogilvie JB, Mountz JM, Bencherif B et al. Localization of parathyroid adenomas by sonography and technetium tc 99m-sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both stud
  9. Ugur O, Bozkurt MF, Rubello D. Nuclear medicine techniques for radio-guided surgery of hyperparathyroidism. Minerva Endocrinol 2008;33:95-104.
  10. Siegel A, Mancuso M, Seltzer M. The spectrum of positive scan patterns in parathyroid scintigraphy. Clin Nucl Med 2007;32:770-4.
  11. Nichols KJ, Tomas MB, Tronco GG, Rini JN, Kunjummen BD, Heller KS et al. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings. Radiology 2008;248:221-32.
  12. Lo CY, Lang BH, Chan WF, Kung AW, Lam KS. A prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism. Am J Surg 2007;193:155-9.
  13. Ansquer C, Mirallié E, Carlier T, Abbey-Huguenin H, Aubron F, Kraeber-Bodéré F. Preoperative localization of parathyroid lesions. Value of 99mTc-MIBI tomography and factors influencing detection. Nuklearmedizin 2008;47:158-62.
  14. Berber E, Parikh RT, Ballem N, Garner CN, Milas M, Siperstein AE. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery 2008;144:74-9.
  15. Lomonte C, Buonvino N, Selvaggiolo M, Dassira M, Grasso G, Vernaglione L et al. Sestamibi scintigraphy, topography, and histopathology of parathyroid glands in secondary hyperparathyroidism. Am J Kidney Dis 2006;48:638-44.
  16. Akinci B, Demir T, Yener S, Comlekci A, Binicier O, Ozdogan O et al. Beneficial effect of endocrinologist-performed ultrasonography on preoperative parathyroid adenoma localization. Endocr Pract 2009;15:17-23.
  17. Moure D, Larrañaga E, Domínguez-Gadea L, Luque-Ramírez M, Nattero L, Gómez-Pan A et al. 99mTc-sestamibi as sole technique in selection of primary hyperparathyroidism patients for unilateral neck exploration. Surgery 2008;144:454-9.
  18. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801-7.
  19. Neumann DR, Esselstyn CB Jr, Go RT, Wong CO, Rice TW, Obuchowski NA. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Am J Roentgenol 1997;169:1671-4.
  20. Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med 2008;49:2012-7.
  21. Merlino JI, Ko K, Minotti A, McHenry CR. The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings. Am Surg 2003;69:225-30.
  22. Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y et al. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 2004;139:1175-9.
  23. Kasai ET, da Silva JW, Mandarim de Lacerda CA, Boasquevisque E. Parathyroid glands: combination of sestamibi-(99m)Tc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands. Rev Esp Med Nucl 2008;27:8-12.
  24. Phitayakorn R, McHenry CR. Incidence and location of ectopic abnormal parathyroid glands. Am J Surg 2006;191:418-23.
  25. Siperstein A, Berber E, Barbosa GF, Tsinberg M, Greene AB, Mitchell J et al. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 2008;248:420-8.
  26. Munk RS, Payne RJ, Luria BJ, Hier MP, Black MJ. Preoperative localization in primary hyperparathyroidism. J Otolaryngol Head Neck Surg 2008;37:347-54.
  27. Papathanassiou D, Flament JB, Pochart JM, Patey M, Marty H, Liehn JC et al. SPECT/CT in localization of parathyroid adenoma or hyperplasia in patients with previous neck surgery. Clin Nucl Med 2008;33:394-7.
  28. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med 2007;48:1084-9.
  29. Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R et al. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg 2006;30:76-83.
  30. Tomas MB, Pugliese PV, Tronco GG, Love C, Palestro CJ, Nichols KJ. Pinhole versus parallel-hole collimators for parathyroid imaging: an intraindividual comparison. J Nucl Med Technol 2008;36:189-94.
  31. Shah S, Win Z, Al-Nahhas A. Multimodality imaging of the parathyroid glands in primary hyperparathyroidism. Minerva Endocrinol 2008;33:193-202.